Tyrosine Kinase Inhibitors. 19. 6-Alkynamides of 4-Anilinoquinazolines and 4-Anilinopyrido[3,4- d ]pyrimidines as Irreversible Inhibitors of the erbB Family of Tyrosine Kinase Receptors
β Scribed by Klutchko, Sylvester R.; Zhou, Hairong; Winters, R. Thomas; Tran, Tuan P.; Bridges, Alexander J.; Althaus, Irene W.; Amato, Danielle M.; Elliott, William L.; Ellis, Paul A.; Meade, Mary Ann; Roberts, Billy J.; Fry, David W.; Gonzales, Andrea J.; Harvey, Patricia J.; Nelson, James M.; Sherwood, Veronica; Han, Hyo-Kyung; Pace, Gerry; Smaill, Jeff B.; Denny, William A.; Showalter, H. D. Hollis
- Book ID
- 119941468
- Publisher
- American Chemical Society
- Year
- 2006
- Tongue
- English
- Weight
- 189 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0022-2623
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a βFull Textβ option. The original article is trackable v
## Abstract Receptor tyrosine kinases such as VEGFR2 (vascular endothelial growth factor receptor 2, KDR) or EGFR (epidermal growth factor receptor) play crucial roles in a variety of diseases, such as cancer. Recently, some pyrrolopyrimidines were shown to be potent EGFR inhibitors. Therefore, new